深静脉血栓形成患者血液中的纤溶酶原激活物抑制剂（PA抑制剂）活性 - Suppr | 超能文献

Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.

作者信息

Paramo J A, de Boer A, Colucci M, Jonker J J, Collen D

出版信息

Thromb Haemost. 1985 Oct 30;54(3):725.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Plasminogen activator inhibitor (PA-inhibitor) activity in the blood of patients with deep vein thrombosis.深静脉血栓形成患者血液中的纤溶酶原激活物抑制剂（PA抑制剂）活性

Thromb Haemost. 1985 Oct 30;54(3):725.

2

Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.组织型纤溶酶原激活物及其快速作用抑制剂血浆水平的术后变化——与深静脉血栓形成的关系及预防的影响

Thromb Haemost. 1985 Oct 30;54(3):713-6.

3

[Fibrinolytic therapy--plasminogen activator inhibitors].

Vasa Suppl. 1988;26:103-6.

4

Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.血小板纤溶酶原激活物抑制剂：人血液中两种不同类型的内皮细胞纤溶酶原激活物抑制剂池。

Thromb Haemost. 1986 Jun 30;55(3):325-9.

5

Tissue plasminogen activator inhibitor in human plasma: development of a functional assay system and demonstration of a correlating Mr = 50,000 antiactivator.人血浆中的组织型纤溶酶原激活物抑制剂：一种功能检测系统的开发及一种相对分子质量为50,000的抗激活剂的相关性证明

J Lab Clin Med. 1985 Jun;105(6):718-24.

6

[Anti-activator inhibitors of plasminogen].[纤溶酶原的抗激活剂抑制剂]

Ann Biol Clin (Paris). 1987;45(2):202-6.

7

Alterations in plasminogen activator and plasminogen activator inhibitor levels during liver transplantation.

Transplant Proc. 1989 Jun;21(3):3540-1.

8

The role of the fibrinolytic system in deep vein thrombosis.

J Lab Clin Med. 1985 Feb;105(2):265-70.

9

Plasma determination of plasminogen activator inhibitor 1 antigen must be performed in blood collected on antiplatelet/anticoagulant mixture.

Thromb Haemost. 1987 Dec 18;58(4):1096.

10

[Changes in plasma tissue plasminogen activator and plasminogen activator inhibitor in acute myocardial infarction and its clinical significance].

Zhonghua Xin Xue Guan Bing Za Zhi. 1988 Aug;16(4):214-6, 254.

引用本文的文献

1

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory.新型冠状病毒肺炎相关血栓形成风险的管理：止血实验室指南

Thromb J. 2020 Sep 7;18:17. doi: 10.1186/s12959-020-00230-1. eCollection 2020.

2

Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue.1型纤溶酶原激活物抑制剂信使核糖核酸和蛋白在小鼠肾组织中的细胞定位

Am J Pathol. 1993 Jan;142(1):59-70.

3

Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.血浆组织型纤溶酶原激活物及1型纤溶酶原激活物抑制剂的术后变化

Surg Today. 1994;24(12):1039-43. doi: 10.1007/BF01367453.